A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A high seroprevalence of antibodies to pertussis toxin among Japanese adults: Qualitative and quantitative analyses
Authors
Keywords
Enzyme-linked immunoassays, Antibodies, Pertussis, Bordetella pertussis, Age groups, CHO cells, Respiratory infections, Adults
Journal
PLoS One
Volume 12, Issue 7, Pages e0181181
Publisher
Public Library of Science (PLoS)
Online
2017-07-11
DOI
10.1371/journal.pone.0181181
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concentrations of Immunoglobulin G Antibodies Against Pertussis Toxin Does Not Decrease Over a Long Period of Time in Japan
- (2016) Yumi Sakakibara et al. INTERNAL MEDICINE
- Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012–2013)
- (2016) Raffaella Palazzo et al. JOURNAL OF MEDICAL MICROBIOLOGY
- A Novel IgM-capture enzyme-linked immunosorbent assay using recombinant Vag8 fusion protein for the accurate and early diagnosis ofBordetella pertussisinfection
- (2016) Nao Otsuka et al. MICROBIOLOGY AND IMMUNOLOGY
- Seroprevalence of Pertussis in The Gambia
- (2015) Susana Scott et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study
- (2015) Xiaomei Li et al. Human Vaccines & Immunotherapeutics
- Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology
- (2014) Sarah L Sheridan et al. Expert Review of Vaccines
- Changing Pertussis Epidemiology: Everything Old is New Again
- (2014) T. A. Clark JOURNAL OF INFECTIOUS DISEASES
- Pertussis Seroprevalence in Korean Adolescents and Adults Using Anti-Pertussis Toxin Immunoglobulin G
- (2014) Soo Young Lee et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia
- (2014) Piia Jõgi et al. VACCINE
- Strategies to control pertussis in infants
- (2013) G. Amirthalingam ARCHIVES OF DISEASE IN CHILDHOOD
- Waning Immunity to Pertussis Following 5 Doses of DTaP
- (2013) S. Y. Tartof et al. PEDIATRICS
- Genetic Analysis of Bordetella pertussis Isolates from the 2008–2010 Pertussis Epidemic in Japan
- (2013) Yusuke Miyaji et al. PLoS One
- Assessment of IgG avidity against pertussis toxin and filamentous hemagglutinin via an adapted enzyme-linked immunosorbent assay (ELISA) using ammonium thiocyanate
- (2012) G. Almanzar et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection
- (2012) Alex-Mikael Barkoff et al. VACCINE
- Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination
- (2012) M. Prelog et al. VACCINE
- Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay*
- (2010) TINE DALBY et al. APMIS
- What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories
- (2010) N. Guiso et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
- (2010) Sabine C. de Greeff et al. PLoS One
- Problem solved: a modified enzyme-linked immunosorbent assay for detection of human antibodies to pertussis toxin eliminates false-positive results occurring at analysis of heat-treated sera
- (2009) Tine Dalby et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More